HERCULES, CA -- (MARKET WIRE) -- March 05, 2007 -- Bio-Rad Laboratories, Inc. (AMEX: BIO) (AMEX: BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostics products, announced today that after its recent appointment of Louis Drapeau to Bio-Rad’s Board of Directors in late February, the American Stock Exchange has confirmed that Bio-Rad is in compliance with AMEX listing rules. Mr. Drapeau will serve on the Board’s Audit Committee. He replaces Philip L. Padou who passed away late last year.
